Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AVIR stock hub

Atea Pharmaceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AVIRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

434.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

AVIR

In the news

Latest news · AVIR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-44.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-31.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AVIR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001593899
Company name	Atea Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	04683R106
Employees	55
Employees Change	-1%
Employees Change Percent	-1.79
Enterprise value	$133.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-10-30
Isin	US04683R1068
Last refreshed	2026-05-10
Market cap	$434.5M
Market cap category	Small-Cap
Price	$5.43
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	AVIR
Website	https://ateapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-36.44%
FCF yield	-30.38%
P/B ratio	1.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-146.5M
Net Income	$-158.3M
Net Income Growth Years	1%
Profit Per Employee	$-2.9M
ROA	-28.75
Roa5y	-11.07
ROCE	-65.13
ROE	-44.34
Roe5y	-19.77
ROIC	-31.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	100.46%
Cagr3y	17.46%
Cagr5y	-23.93%
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$315.2M
Cash	$301.8M
Current Assets	$311M
Current Liabilities	$39.8M
Debt	$843,000
Debt Equity	$0
Equity	$275.4M
Liabilities	$39.8M
Long Term Assets	$4.2M
Long Term Liabilities	$0
Net Cash	$301M
Net Cash By Market Cap	$69.26
Net Cash Growth	-33.57%
Net Debt Equity	$-1.09
Tangible Book Value	$275.4M
Tangible Book Value Per Share	$3.53
WACC	6.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.82
Net Working Capital	$-29.8M
Quick ratio	7.59
Working Capital	$271.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.29%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	100.37%
200-day SMA	3.99
3Y total return	62.09%
50-day SMA	5.62
50-day SMA vs 200-day SMA	50over200
5Y total return	-74.53%
All Time High	94.17
All Time High Change	-94.23%
All Time High Date	2021-02-11
All Time Low	2.46
All Time Low Change	121.18%
All Time Low Date	2025-05-15
ATR	0.24
Beta	0.38
Beta1y	0.42
Beta2y	0.57
Ch YTD	52.1
High	5.57
High52	6.45
High52 Date	2026-03-10
High52ch	-15.81%
Low	5.42
Low52	2.46
Low52 Date	2025-05-15
Low52ch	121.18%
Ma50ch	-3.29%
Price vs 200-day SMA	36.19%
RSI	45.36
RSI Monthly	57.63
RSI Weekly	62.29
Sharpe ratio	1.63x
Sortino ratio	2.73
Total Return	3.29%
Tr YTD	52.1
Tr1m	-9.05%
Tr1w	-2.69%
Tr3m	30.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.56
Operating Income	$-179.4M
Price target	$10
Price Target Change	$84.16

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	60,236,021%
Float Percent	75.27%
Shares Insiders	15.91%
Shares Institutions	66.4%
Shares Out	80,027,099
Shares Qo Q	-1.17%
Shares Yo Y	-3.29%
Short Float	12.76%
Short Ratio	17.94
Short Shares	9.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-152.8M
Average Volume	255,366.45x
Bv Per Share	3.53
Ch1m	-9.05
Ch1w	-2.69
Ch1y	100.4
Ch3m	30.84
Ch3y	62.09
Ch5y	-74.53
Ch6m	66.06
Change	-1.99%
Change From Open	-1.45
Close	5.54
Days Gap	-0.54
Depreciation Amortization	416,000
Dollar Volume	1,301,972.8
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-179.4M
EBITDA	$-179M
EPS	$-1.94
F Score	1
FCF	$-132M
FCF EV Yield	-98.86x
FCF Per Share	$-1.65
Financing CF	-25,745,000
Fiscal Year End	December
Founded	2,012
Income Tax	$-6.2M
Investing CF	188,793,000
Ipr	-77.38
Iprfo	-79.9
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma150	4.2
Ma150ch	29.16%
Ma20	5.6
Ma20ch	-3.07%
Net CF	31,017,000
Next Earnings Date	2026-05-12
Open	5.51
Optionable	Yes
Position In Range	6.67
Post Close	5.43
Postmarket Change Percent	1.84
Postmarket Price	$5.53
Ppne	1,091,000
Price Date	2026-05-08
Ptbv Ratio	1.58
Relative Volume	0.94x
Share Based Comp	20,720,000
Tr6m	66.06%
Us State	Massachusetts
Volume	239,774

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AVIR pay a dividend?

Capital-return profile for this ticker.

Performance

AVIR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AVIR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+66.4%

Float: +75.3% of shares outstanding

Insider ownership

+15.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

AVIR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.4

Neutral momentum band

Price vs 200-day MA

+36.2%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

1.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AVIR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AVIR stock rating?

Atea Pharmaceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AVIR analysis?

The full report lives at /stocks/AVIR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AVIR?

The latest report frames AVIR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AVIR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.